Acute myeloid leukemia (AML) is an aggressive hematological disease that mainly affects
elderly patients. Following the randomized VIALE-A trial, current standard treatment in …

Simple Summary In this review article, we describe the landscape of available treatments for
older and medically unfit patients with AML. We review the historical practice of AML …

目的: 靶向药物BCL-2 抑制剂维奈克拉(venetoclax, VEN) 的出现革新了急性髓系白血病(acute
myeloidleukemia, AML) 的治疗格局, 尤其是对于老年或不适合强化疗的患者 …

This article discusses the validation of the SIE/SIES/GITMO consensus criteria, also known
as the Ferrara criteria, for predicting early mortality and survival in acute myeloid leukemia …

The clinical impact of molecular ontogeny in acute myeloid leukemia (AML) was defined in
patients treated with intensive chemotherapy. In a cohort of 314 newly diagnosed AML …

Objective: To retrospectively analyze the incidence of infections in elderly acute myeloid
leukemia (AML) patients undergoing induction therapy with venetoclax combined with …

Venetoclax is a first-in-class B-cell lymphoma/lymphoma-2 (BCL-2) inhibitor that induces
apoptosis in malignant cells through the inhibition of BCL-2. The clinical response to …

Simple Summary In older AML patients, their clinical fitness is of utmost importance for
choosing the most appropriate therapy. Therefore, treatment-specific fitness criteria were …

Invasive fungal infections (IFIs), mainly due to pulmonary aspergillosis, are considered a
serious complication in acute leukaemia, with an unfavourable impact on patient. In this well …

Time to define and refine maintenance strategies in acute myeloid leukaemia Time to define
and refine maintenance strategies in acute myeloid leukaemia Lancet Haematol. 2024 Apr;11(4):e246-e247 …